Shirasawa, M., Yoshida, T., Matsutani, T., Takeyasu, Y., Goto, N., Yagishita, S., . . . Ohe, Y. Diversity of TCR repertoire predicts recurrence after CRT followed by durvalumab in patients with NSCLC. Nature Portfolio.
Chicago Style (17th ed.) CitationShirasawa, Masayuki, et al. Diversity of TCR Repertoire Predicts Recurrence After CRT Followed by Durvalumab in Patients with NSCLC. Nature Portfolio.
MLA (9th ed.) CitationShirasawa, Masayuki, et al. Diversity of TCR Repertoire Predicts Recurrence After CRT Followed by Durvalumab in Patients with NSCLC. Nature Portfolio.
Warning: These citations may not always be 100% accurate.